I agree that this site is using cookies. You can find further informations here.
X
Jerkeman, M.
~ 100  results:
Search for persons X
?
1

ESMO Clinical Practice Guideline interim update on new targ..:

Eichhorst, B. ; Ghia, P. ; Niemann, C.U....
Annals of Oncology.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

Primary central nervous system lymphomas: EHA–ESMO Clinical..:

Ferreri, A.J.M. ; Illerhaus, G. ; Doorduijn, J.K....
Annals of Oncology.  35 (2024)  6 - p. 491-507 , 2024
Link: https://doi.org/10.1016/..
 
?
3

PHASE 1/2A CLINICAL TRIAL OF BI‐1206, A MONOCLONAL ANTIBODY..:

Jerkeman, M. ; Costa, P. Abrisqueta ; Hagberg, H. E....
Hematological Oncology.  41 (2023)  S2 - p. 835-836 , 2023
Link: https://doi.org/10.1002/..
 
?
4

Multicohort Study of Conditional Survival and Cause of Deat..:

Wang, Y. ; Larson, M. C. ; Ekberg, S....
Hematological Oncology.  41 (2023)  S2 - p. 472-474 , 2023
Link: https://doi.org/10.1002/..
 
?
5

Trends in relative survival of Diffuse large B‐cell lymphom..:

Smedby, K. Ekström ; Antonilli, S. ; Enblad, G....
Hematological Oncology.  41 (2023)  S2 - p. 429-430 , 2023
Link: https://doi.org/10.1002/..
 
?
6

Enhanced ctDNA Profiling Reveals Molecular Determinants of ..:

Meriranta, L. ; Kolstad, A. ; Hutchings, M....
Hematological Oncology.  41 (2023)  S2 - p. 477-478 , 2023
Link: https://doi.org/10.1002/..
 
?
7

A RANDOMIZED TRIAL OF OBSERVATION VERSUS RADIOTHERAPY IN PR..:

Davies, A. J. ; Zucca, E. ; Ceriani, L....
Hematological Oncology.  41 (2023)  S2 - p. 48-50 , 2023
Link: https://doi.org/10.1002/..
 
?
8

HYPOGAMMAGLOBULINEMIA AT DIAGNOSIS IS ASSOCIATED WITH INFER..:

Lindberg, Å. ; Johansson, Å. ; Kahn, F....
Hematological Oncology.  41 (2023)  S2 - p. 726-726 , 2023
Link: https://doi.org/10.1002/..
 
?
9

How to choose between curative radiotherapy or chemotherapy..:

Albertsson‐Lindblad, A. ; Ekberg, S. ; Glimelius, I....
Hematological Oncology.  41 (2023)  S2 - p. 476-477 , 2023
Link: https://doi.org/10.1002/..
 
?
10

SOLUBLE MACROPHAGE MARKER SCD163 PREDICTS OUTCOME IN BOTH C..:

Nikkarinen, A. ; Lokhande, L. ; Amini, R....
Hematological Oncology.  41 (2023)  S2 - p. 746-748 , 2023
Link: https://doi.org/10.1002/..
 
?
11

Secondary malignancies in mantle cell lymphoma patients—A n..:

Abalo, K. ; Smedby, K. E. ; Ekberg, S....
Hematological Oncology.  41 (2023)  S2 - p. 475-476 , 2023
Link: https://doi.org/10.1002/..
 
?
12

P1264: HEMATOPOIETIC CLONES WITH TP53 MUTATIONS EXPAND IN P..:

Husby, S. ; Bæch-Laursen, C. ; Favero, F....
HemaSphere.  6 (2022)  - p. 1149-1150 , 2022
Link: https://doi.org/10.1097/..
 
?
13

S209: PRIMARY RESULTS FROM THE PHASE 3 SHINE STUDY OF IBRUT..:

Wang, M. L. ; Jurczak, W. ; Jerkeman, M....
HemaSphere.  6 (2022)  - p. 110-111 , 2022
Link: https://doi.org/10.1097/..
 
?
14

Myocardial infarction in diffuse large B‐cell lymphoma pati..:

Ekberg, S. ; Harrysson, S. ; Jernberg, T....
Journal of Internal Medicine.  290 (2021)  5 - p. 1048-1060 , 2021
Link: https://doi.org/10.1111/..
 
?
15

HIGH RISK AGGRESSIVE B‐CELL LYMPHOMA ON THE LIQUID BIOPSY:

Meriranta, L ; Alkodsi, A ; Pasanen, A...
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
1-15